[{"address1": "828 Winter Street", "address2": "Suite 300", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "857-524-2466", "website": "https://xiliotx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of tumor-activated immuno-oncology therapies. The company's checkpoint inhibitor program includes XTX101, an investigational Fc-enhanced, tumor-activated anti-CTLA-4 mAb that is in Phase 2 clinical trial for patients with advanced solid tumors. It also develops cytokine programs, which comprises XTX202, a tumor-activated beta-gamma biased IL-2, currently under Phase 2 clinal trials; and XTX301, an investigational tumor-activated, engineered IL-12 molecule, currently under Phase 1 studies. The company was founded in 2016 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 64, "companyOfficers": [{"maxAge": 1, "name": "Dr. Rene  Russo BCPS, Pharm.D.", "age": 49, "title": "President, CEO & Director", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 966228, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher  Frankenfield", "age": 42, "title": "CFO & COO", "yearBorn": 1982, "fiscalYear": 2024, "totalPay": 786196, "exercisedValue": 0, "unexercisedValue": 260}, {"maxAge": 1, "name": "Dr. Katarina  Luptakova M.D.", "age": 48, "title": "Chief Medical Officer", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 661890, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kevin M. Brennan", "age": 54, "title": "Senior Vice President of Finance & Accounting", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Uli  Bialucha Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Caroline  Hensley", "title": "Chief Legal Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Scott  Coleman Ph.D.", "title": "Chief Development Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.8, "open": 0.79, "dayLow": 0.783, "dayHigh": 0.9, "regularMarketPreviousClose": 0.8, "regularMarketOpen": 0.79, "regularMarketDayLow": 0.783, "regularMarketDayHigh": 0.9, "payoutRatio": 0.0, "beta": -0.233, "forwardPE": -1.4817241, "volume": 825321, "regularMarketVolume": 825321, "averageVolume": 1415320, "averageVolume10days": 5157350, "averageDailyVolume10Day": 5157350, "bid": 0.8486, "ask": 0.8917, "bidSize": 3, "askSize": 1, "marketCap": 44501708, "fiftyTwoWeekLow": 0.62, "fiftyTwoWeekHigh": 1.7, "priceToSalesTrailing12Months": 4.7985454, "fiftyDayAverage": 0.76778, "twoHundredDayAverage": 0.88827, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -24875508, "profitMargins": 0.0, "floatShares": 31729727, "sharesOutstanding": 51782300, "sharesShort": 351157, "sharesShortPriorMonth": 644535, "sharesShortPreviousMonthDate": 1743379200, "dateShortInterest": 1745971200, "sharesPercentSharesOut": 0.0068, "heldPercentInsiders": 0.28177, "heldPercentInstitutions": 0.40575, "shortRatio": 1.73, "shortPercentOfFloat": 0.0099, "impliedSharesOutstanding": 51775400, "bookValue": 0.143, "priceToBook": 6.00979, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -54303000, "trailingEps": -0.65, "forwardEps": -0.58, "enterpriseToRevenue": -2.682, "enterpriseToEbitda": 0.449, "52WeekChange": -0.36, "SandP52WeekChange": 0.11469197, "quoteType": "EQUITY", "currentPrice": 0.8594, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "totalCash": 89073000, "totalCashPerShare": 1.192, "ebitda": -55345000, "totalDebt": 0, "quickRatio": 1.128, "currentRatio": 1.128, "totalRevenue": 9274000, "revenuePerShare": 0.142, "returnOnAssets": -0.38211, "returnOnEquity": -2.97836, "grossProfits": 11408000, "grossMargins": 1.23011, "ebitdaMargins": 0.0, "operatingMargins": -4.7273, "financialCurrency": "USD", "symbol": "XLO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketChangePercent": -3.42099, "postMarketPrice": 0.83, "postMarketChange": -0.0294, "regularMarketChange": 0.059399962, "regularMarketDayRange": "0.783 - 0.9", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1415320, "fiftyTwoWeekLowChange": 0.23939997, "fiftyTwoWeekLowChangePercent": 0.386129, "fiftyTwoWeekRange": "0.62 - 1.7", "fiftyTwoWeekHighChange": -0.8406001, "fiftyTwoWeekHighChangePercent": -0.49447063, "fiftyTwoWeekChangePercent": -36.0, "earningsTimestamp": 1746703800, "earningsTimestampStart": 1754479858, "earningsTimestampEnd": 1754911858, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.65, "epsForward": -0.58, "fiftyDayAverageChange": 0.09161997, "fiftyDayAverageChangePercent": 0.11933102, "twoHundredDayAverageChange": -0.028870046, "twoHundredDayAverageChangePercent": -0.03250143, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-10-22", "averageAnalystRating": "1.0 - Strong Buy", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1634909400000, "regularMarketChangePercent": 7.4249954, "regularMarketPrice": 0.8594, "corporateActions": [], "postMarketTime": 1747439956, "regularMarketTime": 1747425600, "exchange": "NMS", "messageBoardId": "finmb_365333564", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "cryptoTradeable": false, "shortName": "Xilio Therapeutics, Inc.", "longName": "Xilio Therapeutics, Inc.", "displayName": "Xilio Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-05-17"}]